A B S T R A C T Sulfasalazine (salicylazosulfapyridine), an agent widely used for the treatment of ileitis and colitis, is also a competitive inhibitor of intestinal folate transport (1, 2). The mechanism of action of sulfasalazine remains uncertain. To further explore the mechanism of sulfasalazine action, the interaction of the drug with the folate recognition site was tested with three enzymes: dihydrofolate reductase, methylenetetrahydrofolate reductase, and serine transhydroxymethylase, each catalyzing a reaction involving a different folate derivative. Each of these enzymes was inhibited by sulfasalazine in the same concentration range as that previously observed to inhibit intestinal folate transport; the kinetic data are consistent with a competitive mode of inhibition. Specificity of inhibition was demonstrated by the finding that the reduction of the pteridine ring of pteroylheptaglutamic acid by dihydrofolate reductase was subject to inhibition, whereas the hydrolysis of the y-glutamyl peptide side chain by chicken pancreas conjugase was not affected. These results are interpreted to indicate that sulfasalazine interferes with a folate recognition site which is common to these enzymes and to the intestinal transport system. Sulfasalazine, therefore, has certain properties of an antifolate drug.
INTRODUCTION
Sulfasalazine, commonly employed in the treatment of inflammatory bowel disease, is composed of sulfapyridine and 5-aminosalicylate linked through an azo G. Jeelani Dhar was the recipient of the Daland Fellowship of the American Philosophical Society.
Received for publication 6 September 1977 and in revised form 17 October 1977. bond ( Fig. 1 ). There is no convincing structural similarity between this compound and folic acid. Yet earlier data from this laboratory (1, 2) has shown that sulfasalazine is a competitive inhibitor of folate transport by the intestine. Stilfapyridinie or 5-anminosalicylate, singly or in combination, were without effect.
Inasmuch as the intestinal transport process is shared by all folate derivatives tested (2, 3) , it was assumed that sulfasalazine blocks a site that is (5) and purification on a DEAE-cellulose columnn (6) . This compound was stored in evacuated vials in a refrigerator (7) . Dih,vdrofolate reductase was prepared from rat liver as described by Peterson et al. (8) with the exception of the affinity chromatography step. The enizyme was assayed by the method of Rothenberg (9) the three enzymes and the intestinal folate transport system are given in Table 1 . In the preceeding experiments sulfasalazine was tested against enzymes, each employing a different monoglutamyl folate derivative as a substrate. In this experiment the inhibitor was tested for its effectiveness against enzymes which act on different sites of the same substrate. Reduction of the pteridine ring of pteroylheptaglutamate by dihydrofolate reductase was inhibited (Fig. 4) whereas sulfasalazine had no effect on the hydrolysis of the y-glutamyl peptide chain by chicken pancreas conjugase.
droxymethylase were prepared from rat liver by homogenization in fouir volumes of water and precipitation with ammonium sulfate at 55% saturation (10) . The first enzyme was assayed in its reverse reaction by the method described by Kutzbach and Stokstad (11) . Serine transhydroxymethylase was assayed by the extent of methylenetetrahydrofolate formation from L-[3-14C]serine and tetrahydrofolate (12) .
Chicken pancreas conjugase was prepared from the acetone powder (Difco Laboratories, Detroit, Mich.) as described by Eigen and Shockman (13) . Activity was determined by the extent of the hydrolysis of 1 ,Imol of [3H]pteroylheptaglutamate at pH 7.0 after 10 min incubation at 37°C. The product of the reaction was determined by Lactobacillus casei (ATCC 7469) uptake after 10 min incubation (14) .
Enzyme activities were determined after incubation at 37°C for 10 min except for methylenetetrahydrofolate reductase which was incubated at 32°C for 10 min. Sulfasalazine (Pharmacia Fine Chemicals, Uppsala, Sweden) was dissolved by heating in a boiling water bath with 0.005 M potassium phosphate buffer, pH 7.0. It was added to the reaction mixtures before the addition of the enzyme solutions. None of the procedures employed for determination of reaction product was affected by this compound.
RESULTS
Sulfasalazine inhibited each of the three enzymes tested in a dose-dependent fashion as shown in Fig. 2 . Ofthe three, methylene-tetrahydrofolate reductase was the most sensitive to inhibition. Under identical assay conditions dihydrofolate reductase was not inhibited by the metabolites of sulfasalazine, sulfapyridine, and 5-amino salicylate, either alone or in combination.
The kinetic analysis shown in Fig. 3 indicates that sulfasalazine competed specifically with the folate substrates. When tested against varying concentrations of the corresponding folate substrates of each of the three enzymes, the drug affected the K,, but not the Vmax of the reactions. Sulfasalazine did not compete with nonfolate substrates such as serine by serine transhydroxymethylase (Fig. 3 d) . When tested against changing serine concentrations at constant concentration of tetrahydrofolate, sulfasalazine affected the Vmax, not the K,,,, which is consistent with the noncompetitive mode of inhibition at the serine binding site.
The affinity constants of substrates and inhibitor of DISCUSSION Three enzymes, each with a specific folate substrate, were inhibited by sulfasalazine, and the inhibition was competitive with respect to the folate substrate with inhibition constants within one order of magnitude (Table I) (16) . Current concepts emphasize the importance of bacterial lysis of the azo linkage with local release of 5-aminosalicylate and the sulfa moiety in the intestine (17, 18) . However, 10-15% of sulfasalazine is absorbed intact in the proximal intestine (16) (17) (18) 
